These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27908621)

  • 1. Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.
    Falkson CB; Vella ET; Yu E; El-Mallah M; Mackenzie R; Ellis PM; Ung YC
    Clin Lung Cancer; 2017 Mar; 18(2):105-121.e5. PubMed ID: 27908621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB; Grills IS; Kestin LL; Robertson JM
    Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer.
    Falkson CB; Vella ET; Yu E; El-Mallah M; Mackenzie R; Ellis PM; Ung YC
    Curr Oncol; 2017 Feb; 24(1):e44-e49. PubMed ID: 28270731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new index comparable to BED for evaluating the biological efficacy of hypofractionated radiotherapy schemes on early stage non-small cell lung cancer: analysis of data from the literature.
    Kong C; Guo WJ; Zha WW; Zhu XZ; Huang SF; Zhang YW; Xu JH; He X
    Lung Cancer; 2014 Apr; 84(1):7-12. PubMed ID: 24548340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stereotactic Body Radiotherapy for Early Stage NSCLC - What Is the Evidence?].
    Guckenberger M
    Zentralbl Chir; 2017 Sep; 142(S 01):S17-S25. PubMed ID: 28958106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Therapy for Stage I Nonoperable or Medically Inoperable Lung Cancer.
    Kishan AU; Lee P
    Semin Respir Crit Care Med; 2016 Oct; 37(5):716-726. PubMed ID: 27732993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered fractionation schemes in radiotherapy.
    Stuschke M; Pöttgen C
    Front Radiat Ther Oncol; 2010; 42():150-156. PubMed ID: 19955801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.
    Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G
    J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
    Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
    Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
    Swaminath A; Wierzbicki M; Parpia S; Wright JR; Tsakiridis TK; Okawara GS; Kundapur V; Bujold A; Ahmed N; Hirmiz K; Kurien E; Filion E; Gabos Z; Faria S; Louie AV; Owen T; Wai E; Ramchandar K; Chan EK; Julian J; Cline K; Whelan TJ
    Clin Lung Cancer; 2017 Mar; 18(2):250-254. PubMed ID: 27876603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
    Moore S; Leung B; Wu J; Ho C
    Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
    Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer].
    Wan Y; Huang J; Xu F
    Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):413-418. PubMed ID: 29764593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer.
    Li C; Wang L; Wu Q; Zhao J; Yi F; Xu J; Wei Y; Zhang W
    Medicine (Baltimore); 2020 Aug; 99(34):e21715. PubMed ID: 32846789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should stereotactic body radiotherapy doses be adjusted according to tumor size in early-stage non-small-cell lung cancer? A systematic review and meta-analysis.
    Luo H; Cui Y; Song H; Mao R; Gao Q; Ge H
    Future Oncol; 2019 Sep; 15(26):3071-3079. PubMed ID: 31426674
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
    Sher DJ; Wee JO; Punglia RS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.